Sander Deventer Van Net Worth & Insider Trades
Sander Deventer Van - Director, Argos Therapeutics Inc
What is Sander Deventer Van's Net Worth?
The current estimated net worth of Argos Therapeutics Inc's Director, Sander Deventer Van, is estimated to be about $1.22M . Sander Deventer Van owns about 6,199,961 units of Argos Therapeutics Inc common stock. In the last 3 years at Argos Therapeutics Inc, Sander Deventer Van has sold an estimated value of $0 worth.
What is Sander Deventer Van's Past Insider Trading?
In total, Sander Deventer Van has made about 10 transactions over 3 years of their time at Argos Therapeutics Inc. Sander Deventer Van usually trades in July, June and March, with the busiest year in 2016. The most recent transaction was a purchase order of 1,545,454 units , worth over $0 on August 4, 2016.
Sander Deventer van
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Sander Deventer Van's' Mailing Address?
- Mailing address is Postbus 5187 Naarden P7 1410 AD Netherlands
Argos Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Jeffrey D. Abbey | 2016 | $450,000 | $356,500 | $1,029,892 | $26,477 | $1,862,869 |
| Jeffrey D. Abbey | 2015 | $450,000 | $202,500 | $714,502 | $14,861 | $1,381,863 |
| Charles A Nicolette, Ph.D. | 2016 | $325,000 | $121,875 | $720,925 | $18,669 | $1,186,469 |
| Charles A Nicolette, Ph.D. | 2015 | $325,000 | $108,875 | $446,564 | $17,217 | $897,656 |
| Lee F. Allen, M.D., Ph.D. | 2016 | $407,292 | $389,375 | $1,016,592 | $70,120 | $1,883,379 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1105533/000117184317003980/def14a_070617.htm
What are Argos Therapeutics Inc's Past Insider Trades?
Argos Therapeutics Inc's most recent insider trade came on January 12, 2018 by Lori R Harrelson who sold 64,329 units worth $10.59K . In the last 4 years, insiders at Argos Therapeutics Inc have sold an estimated value of $79.34M and bought an estimated value of $13.75M worth of shares. Insider trading is most common in January, with the busiest year in 2016. The most active traders at the company are Jeffrey Abbey, Chief Executive Officer, Pharmstandard Co Stock Joint, and Sa International Pharmstandard .
ARGOS THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||